Torrent Pharmaceuticals Ltd.
NSE: TORNTPHARM · Healthcare
Sector
Healthcare
Size band
Large cap
Market cap
1,37,043cr
P/E
62.3
ROE
26.2%
Dividend yield
0.8%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 29.0% | 10.5% |
| Divi's Laboratories Ltd. | 41.0% | 27.8% |
| Torrent Pharmaceuticals Ltd. | 34.0% | 54.8% |
| Lupin Ltd. | 30.0% | 32.1% |
| Dr. Reddy's Laboratories Ltd. | 11.0% | −5.5% |
| Cipla Ltd. | 17.0% | 2.3% |
| Zydus Lifesciences Ltd. | 24.0% | 22.0% |
| Mankind Pharma Ltd. | 26.0% | 12.9% |
| Aurobindo Pharma Ltd. | 21.0% | 16.3% |
| Torrent Power Ltd. | 19.0% | 2.8% |
| Alkem Laboratories Ltd. | 20.0% | 10.9% |
| Glenmark Pharmaceuticals Ltd. | 20.0% | 23.1% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Torrent Pharmaceuticals Ltd..
On air
8 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| CNBC AwaazCNBC Awaax · no registration attached | 28 Aug | +7.5% | -3.5% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 27 Aug | +2.0% | -1.2% | still open |
| Zee BusinessZee Business · no registration attached | 19 Aug | +10.6% | -5.4% | still open |
| Zee BusinessZee Business · no registration attached | 19 Aug | +1.6% | -0.6% | still open |
| Zee BusinessZee Business · no registration attached | 19 Aug | +0.8% | -1.9% | still open |
| Zee BusinessZee Business · no registration attached | 18 Aug | +1.6% | -0.6% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 3 Aug | +60.3% | -30.1% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 3 Aug | +3.0% | -1.4% | still open |
Filings
latest 25 of 290- Analysts/Institutional Investor Meet/Con. Call Updates11 Aug 2026
- General Updates11 Aug 2026
- Copy of Newspaper Publication6 Aug 2026
- Shareholders meeting5 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates4 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026
- Change in Management30 Jul 2026
- Press Release30 Jul 2026
- Outcome of Board Meeting30 Jul 2026
- Appointment28 Jul 2026
- General Updates27 Jul 2026
- General Updates20 Jul 2026
- Disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 - Dissolution of Wholly Owned Subsidiary (WOS)17 Jul 2026
- General Updates17 Jul 2026
- General Updates17 Jul 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - ESG Rating17 Jul 2026
- Analysts/Institutional Investor Meet/Con. Call Updates17 Jul 2026
- Press Release9 Jul 2026
- Copy of Newspaper Publication8 Jul 2026
- Amendment to AOA/MOA8 Jul 2026
- General Updates8 Jul 2026
- Record Date7 Jul 2026
- General Updates7 Jul 2026
- General Updates6 Jul 2026
- Trading Window26 Jun 2026
The 25 most recent of 290 filings we hold for TORNTPHARM, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.